news

Indigo will be present during the ADA 2019 conference on June 7-11 in San Francisco, USA. If you are interested to talk to us, we will be delighted to meet you. Please contact us danae.delbeke@indigomed.com (+32 475 41 21 32) or tom.segers@indigomed.com (+32 496 59 07...

Indigo is pleased to announce that the first patient has now been enrolled into ‘Action-1”, the company’s prospective, non-randomized, interventional, multi-center data collection study. The study collects venous blood samples in male T1D patients to evaluate the...

We are extremely proud to announce the opening of our new lab in Ghent! We spent a couple of months building up a lab that provides all necessary equipment for our research and development. This is a huge improvement for our team. At Indigo we are committed to making...

Flanders Innovation and Entrepreneurship rewards Indigo a grant to support the development its next generation CGM device December 1, 2018 Flanders Innovation & Entrepreneurship (Vlaio) stimulates innovation in Flanders and therefore finances research and...

Our DiaMOND Project on EASME. Personalised Diabetes Management using lOw-cost Needle-free multiple-biomarkers monitoring device.

Spin-off from UGent and imec is launched to develop the next generation needle-free glucose sensors, paving way to a paradigm shift in diabetes management.